Abstract
A commentary on current national and international regulation of benzodiazepine-like drugs is presented. The policies and decision making associated with these regulations also are discussed, both in terms of historical mistakes and current problems. Finally, a proposal is made to improve the methods by which regulations are put into effect.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 773-782 |
| Number of pages | 10 |
| Journal | Journal of Clinical Pharmacology |
| Volume | 38 |
| Issue number | 9 |
| State | Published - Sep 1 1998 |
| Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)